Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy Study
- 25 May 2023
- journal article
- research article
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 21 (6) , 669-678
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 CA276308)
- U.S. Department of War (W81XWH-19-1-0624)
- Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
- Institute for Prostate Cancer Research
- Kuni Foundation
- Seattle Translational Tumor Research
This publication has 24 references indexed in Scilit:
- Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsyJCI Insight, 2019
- Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomyUrologic Oncology: Seminars and Original Investigations, 2018
- The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancerOncotarget, 2017
- Enfortumab Vedotin Antibody–Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer ModelsCancer Research, 2016
- Expression and clinical significance of Nectin-4 in hepatocellular carcinomaOncoTargets and Therapy, 2016
- HTSeq—a Python framework to work with high-throughput sequencing dataBioinformatics, 2014
- Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancerOncogenesis, 2014
- Trop-2 Is a Determinant of Breast Cancer SurvivalPLOS ONE, 2014
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Expression of Trop2 Cell Surface Glycoprotein in Normal and Tumor TissuesJournal of Histochemistry & Cytochemistry, 2011